To date, no rapid diagnostic tests have been validated and licensed for the indication of screening for seropositivity. Dengue IgG ELISA could potentially be used for screening (enzyme-linked immunosorbent assay). Currently available Rapid Diagnostic Tests could be considered in high transmission settings.